-- QingSong Health (HKG:2661) embedded its artificial intelligence-based medical agent QSevidence within its QSmedical platform, according to a Hong Kong bourse filing on Sunday.
QSevidence is an evidence-based medical agent designed to help physicians make medical decisions.
The embedding comes amid a 46% year on year rise in the number of medical professional users on the company's QSmedical platform in the first quarter of the year. The firm said 69,615 professionals were using its platform as of March 31, compared with 47,554 in the same period last year.